Abound Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31.9K | Sell |
72
-5
| -6% | -$2.22K | 0.01% | 266 |
|
|
2025
Q1 | $37.2K | Sell |
77
-16
| -17% | -$7.73K | 0.01% | 226 |
|
|
2024
Q4 | $37.3K | Buy |
93
+1
| +1% | +$401 | 0.01% | 207 |
|
|
2024
Q3 | $42.7K | Sell |
92
-2
| -2% | -$927 | 0.01% | 197 |
|
|
2024
Q2 | $43.9K | Hold |
94
| – | – | 0.02% | 164 |
|
|
2024
Q1 | $39.2K | Buy |
94
+1
| +1% | +$417 | 0.01% | 170 |
|
|
2023
Q4 | $37.8K | Buy |
93
+43
| +86% | +$17.5K | 0.02% | 175 |
|
|
2023
Q3 | $17.4K | Buy |
50
+3
| +6% | +$1.04K | 0.01% | 235 |
|
|
2023
Q2 | $16.5K | Buy |
47
+11
| +31% | +$3.87K | 0.01% | 247 |
|
|
2023
Q1 | $11.3K | Buy |
36
+6
| +20% | +$1.89K | 0.01% | 273 |
|
|
2022
Q4 | $8.66K | Buy |
30
+15
| +100% | +$4.33K | ﹤0.01% | 280 |
|
|
2022
Q3 | $4.34K | Buy |
+15
| New | +$4.34K | ﹤0.01% | 379 |
|